Sherpa Healthcare Partners
Private equityGrand Cayman · Seed–Late Stage · 1 people tracked
Also known as SHERPA HEALTHCARE PARTNERS CO., LTD.
Investment thesis
Early- to growth-stage biotech and life sciences firm with a cross-border US–China–Germany–France focus, deep-science and platform specialization, experienced pre-assembled team, and go-to syndicate partner for complex Series A/B rounds.
Source: firm website, verified Aug 25, 2026.
Team · 1 people
from public directoriesWhat they invest in
from 3 of 3 portfolio companiesBiotech ×3Digital Health ×1FoodTech ×1Healthtech ×1New Materials ×1
HQs:China×2
Investments · 3 tracked
founders shown can be your intro pathAlebund Pharmaceuticals develops innovative treatments for kidney diseases, with a pipeline covering chronic kidney conditions such as diabetic nephropathy, IgA nephropathy, FSGS, and ADPKD, as well as end-stage renal disease complications like hyperphosphatemia and anemia.
BiotechDigital HealthShanghai, CN
Co-investorsLAVLilly Asia VenturesQuan Capital3E Bioventures Capital
Bota Bio operates a proprietary Biofoundry platform combining computational algorithms with biotechnology to accelerate design-build-test-learn cycles for bio-manufacturing.
BiotechFoodTechNew Materials
Co-investorsHongShan Capital GroupNSG VenturesSource Code CapitalMatrix Partners China
EpimAb Biotherapeutics develops bispecific antibody drugs for immuno-oncology and other high-need therapeutic areas using its proprietary FIT-Ig platform, with a pipeline of clinical programs (EMB-01, EMB-06, EMB-07) and preclinical candidates.
BiotechHealthtechShanghai, CN
Co-investorsDecheng CapitalShangBay Capital LLCTCG Labs3E Bioventures Capital
Portfolio news
latest coverage across their companiesAlebund · fiercebiotech.com · Aug 12, 2026
Fund performance · per public LP disclosures · 3
as of Sep 2025| Fund | Vintage | Committed | Net IRR | TVPI | DPI |
|---|---|---|---|---|---|
| Sherpa Healthcare Fund IILPs: Oregon Public Employees Retirement System | 2021 | — | 2.5% | 1.08x | 0.10x |
| Sherpa Healthcare Co-Investment FundLPs: Oregon Public Employees Retirement System | 2020 | — | -1.6% | 0.94x | 0.00x |
| Sherpa Healthcare Fund ILPs: Oregon Public Employees Retirement System | 2019 | — | 6.7% | 1.33x | 0.15x |
Source: public limited-partner disclosures (CalPERS, CalSTRS). Net IRR / TVPI / DPI as reported by the limited partner; a fund's early-year IRR is an interim estimate (J-curve).
Frequently asked questions
- What stage does Sherpa Healthcare Partners invest at?
- Sherpa Healthcare Partners invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.
- What sectors does Sherpa Healthcare Partners focus on?
- Sherpa Healthcare Partners focuses on Biotech, Healthtech, Medical Devices.
- Where is Sherpa Healthcare Partners located?
- Sherpa Healthcare Partners is headquartered in Grand Cayman, CN.
- Does Sherpa Healthcare Partners lead rounds?
- Sherpa Healthcare Partners typically participates in rounds rather than leading them.
Similar investors
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Capricorn Partners is a Belgium-based, partner-owned independent management company for alternative investment funds, investing in innovative companies across digital, health and clean technologies with an ESG focus.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Korea Investment Partners is a South Korea-based venture capital firm that invests across multiple stages from early-stage startups through growth and buyout transactions, including venture debt and mezzanine financing. The firm operates across venture capital, middle market, and growth equity investment categories.